Multiple Myeloma Clinical Trials

2650 clinical trials for Multiple Myeloma across international registries, including 423 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma — RECRUITING · PHASE3
• MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) — RECRUITING · PHASE3
• A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma — RECRUITING · PHASE1
• A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments — RECRUITING · PHASE3
• Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer — RECRUITING · PHASE2
• DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics — RECRUITING · NA
• A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM) — RECRUITING · PHASE1
• Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients — RECRUITING
• 18F-Fluciclovine PET/CT in Multiple Myeloma — RECRUITING · PHASE2
• Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT) — RECRUITING · NA
• A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects — RECRUITING · PHASE1
• Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD) — RECRUITING · NA
• A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma — RECRUITING · PHASE2
• RAT-HEMATO : Return to Work After Malignant Hemopathy — RECRUITING · NA
• Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma — RECRUITING · PHASE2
• Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies — RECRUITING · PHASE1
• Delayed Toxicities Post-CAR-T — RECRUITING
• Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients With Relapsed/Refractory Multiple Myeloma — RECRUITING · PHASE1
• Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma — RECRUITING · PHASE1
• ASCT in Combination With C-CAR088 for Treating Patients With Ultra High-risk Multiple Myeloma (MM) — RECRUITING · PHASE1
• Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances — RECRUITING · PHASE1
• A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma — RECRUITING · PHASE3
• MRD-Guided BCMA/CD3 Bispecific Antibody Treatment After Stem Cell Transplant for Newly Diagnosed Multiple Myeloma — RECRUITING · PHASE2
• Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance — RECRUITING · PHASE2
• A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy — RECRUITING · NA
• A Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Cevostamab in Chinese Participants With Relapsed or Refractory Multiple Myeloma — RECRUITING · PHASE1
• A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma — RECRUITING · PHASE2
• A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma — RECRUITING · PHASE1
• Tissue Collection for Studies of Lymph Cancer — RECRUITING
• Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies — RECRUITING
• Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols — RECRUITING
• Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma — RECRUITING · PHASE3
• A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL). — RECRUITING · PHASE2
• Mosaic Trial for Stem Cell Transplant Recipients — RECRUITING · NA
• A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma — RECRUITING · PHASE3
• Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE) — RECRUITING
• A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma — RECRUITING · PHASE3
• A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events — RECRUITING · PHASE2
• A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or in Combination With Pomalidomide for Multiple Myeloma — RECRUITING · PHASE1
• A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma — RECRUITING · PHASE2
• A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma — RECRUITING · PHASE2
• A Clinical Study of SHR-5421 in Patients With Multiple Myeloma — RECRUITING · PHASE1
• The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas — RECRUITING · PHASE2
• A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma — RECRUITING · PHASE1
• Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant — RECRUITING · NA
• Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy — RECRUITING · NA
• A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM) — RECRUITING · PHASE2
• Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid — RECRUITING · NA
• A Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Cevostamab in Combination with Pomalidomide and Dexamethasone Versus Standard of Care in Patients with Multiple Myeloma who Have Received One to Three Prior Lines of Therapy — RECRUITING · PHASE3
• Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial — RECRUITING · PHASE4

Refine this search